AVNRT epidemiology and demographics

Revision as of 15:23, 9 September 2012 by C Michael Gibson (talk | contribs)
Jump to navigation Jump to search

AVNRT Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating AVNRT from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diaagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Overview

Medical Treatment

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

AVNRT epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of AVNRT epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on AVNRT epidemiology and demographics

CDC on AVNRT epidemiology and demographics

AVNRT epidemiology and demographics in the news

Blogs on AVNRT epidemiology and demographics

Directions to Hospitals Treating AVNRT

Risk calculators and risk factors for AVNRT epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

AV nodal reentrant tachycardia is the most common regular supraventricular tachycardia and accounts for 60% to 70% of these cases.

Sex

The ratio of female to male involvement is 3:1

Age

There is no age predilection.

References